Jardiance

BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models

Fierce Biotech

Fri, 04/19/19 - 10:34 am

New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease

CP Wire

Wed, 10/10/18 - 10:13 am

New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease

Wed, 10/10/18 - 10:08 am

Jardiance

Boehringer Ingelheim

Eli Lilly

CHMP Issues Positive Opinion to Expand Labeling of Jardiance, Synjardy and Glyxambi to Include Positive Effects on Cardiovascular and Renal Outcomes

CP Wire

Mon, 07/2/18 - 10:02 am

CHMP Issues Positive Opinion to Expand Labeling of Jardiance, Synjardy and Glyxambi to Include Positive Effects on Cardiovascular and Renal Outcomes

Mon, 07/2/18 - 09:26 am

5 Biggest Blockbuster Diabetes Drugs of the Future

Motley Fool

Sun, 06/24/18 - 10:04 am

Novo Nordisk's oral diabetes drug beats Jardiance in study

Yahoo/Reuters

Tue, 05/29/18 - 11:07 pm

Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise

Fierce Pharma

Wed, 03/7/18 - 12:00 pm

Boehringer strikes Jardiance outcomes deal with Prime PBM

Biopharma Dive

Thu, 02/1/18 - 09:55 am

outcomes-based contracts

Boehringer Ingelheim inks outcomes-based contract with pharmacy benefit manager for diabetes drug

Drug Delivery Business News

Mon, 01/29/18 - 03:20 pm

Boehringer Ingelheim

PBMs

outcomes-based contracts

diabetes

Jardiance

Prime Therapeutics

J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits

Fierce Pharma

Fri, 11/24/17 - 09:23 am

Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD

NASDAQ.com

Thu, 11/16/17 - 09:36 am

Boehringer's new risk-prediction model will tap patients who could be good Jardiance candidates

Fierce Pharma

Wed, 09/27/17 - 11:19 am

EASD: Boehringer Ingelheim, Lilly's Jardiance holds CV benefit regardless of blood sugar starting point

Fierce Pharma

Thu, 09/14/17 - 11:27 am

J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances

Fierce Pharma

Wed, 07/19/17 - 07:47 pm

BI, Lilly hit the streets to talk up Jardiance's cardiovascular benefits

Fierce Pharma

Wed, 06/28/17 - 10:13 am

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Medical Marketing and Media

Thu, 06/22/17 - 09:32 am

AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study

Fierce Pharma

Wed, 06/14/17 - 09:00 pm

J&J's Invokana lowers CV risk, but by enough to compete?

BioPharma Dive

Wed, 06/14/17 - 11:37 am

ADA: Merck, Pfizer notch success, but late with SGLT-2 data

BioPharma Dive

Tue, 06/13/17 - 12:15 pm

Search form

You are here

Jardiance

Pages